Colorectal Cancer Evidence-based Chemotherapy Strategies /
Management options for patients with colorectal cancer have undergone d- matic changes over the past decade. Whereas at the start of 1996 only one drug, 5-Fluorouracil, was available for the treatment of this disease, a mere 10 yr later, six drugs are licensed for use in colorectal cancer, and other...
Saved in:
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2007.
|
| Edition: | 1st ed. 2007. |
| Series: | Current Clinical Oncology,
|
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-1-59745-215-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Molecular Biology of Colon Cancer
- Chemoprevention of Colorectal Cancer
- Colorectal Cancer Screening and Surveillance
- Cytotoxic Chemotherapy for Metastatic Colorectal Cancer
- Integration of Antiangiogenic Strategies Into Colorectal Cancer Treatment
- The Role of EGFR Inhibition in Colorectal Cancer
- Second-Line Strategies in the Treatment of Patients With Metastatic Colorectal Cancer
- Adjuvant Chemotherapy for Colon Cancer
- Management of Locally Advanced Rectal Cancer
- Rationale for Adjuvant and Neoadjuvant Chemotherapy in the Resection of Liver Metastases
- Percutaneous Radiofrequency Ablation in the Management of Patients With Colorectal Cancer
- Colorectal Cancer Imaging
- Nursing Issues in Colorectal Cancer Chemotherapy
- Pain Management in the Colorectal Cancer Patient
- Novel Agents and New Paradigms for Colorectal Cancer Beyond EGFR and VEGF.